Bristol Myers Company Insiders

Bristol Myers' latest congressional trading

Bristol Myers Management Team Effectiveness

The company has Return on Asset of 0.0607 % which means that on every $100 spent on assets, it made $0.0607 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.3133) %, meaning that it generated no profit with money invested by stockholders. Bristol Myers' management efficiency ratios could be used to measure how well Bristol Myers manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Bristol Myers' Return On Capital Employed is fairly stable compared to the past year. Return On Assets is likely to rise to 0.14 in 2024, whereas Return On Tangible Assets are likely to drop 0.15 in 2024. At this time, Bristol Myers' Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 66.6 B in 2024, whereas Other Assets are likely to drop slightly above 3.3 B in 2024. Net Income Applicable To Common Shares is likely to rise to about 6 B in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 1.6 B in 2024.

Bristol Myers Workforce Comparison

Bristol Myers Profit Margins

The company has Net Profit Margin of (0.15) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of 0.18 %, which entails that for every 100 dollars of revenue, it generated $0.18 of operating income.

Bristol Myers Insider Trading History

Bristol Myers Notable Stakeholders

The success or failure of an entity such as Bristol Myers Squibb often depends on how effective the management is. Bristol Myers management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Bristol management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Bristol management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Bristol Myers' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Bristol Myers Squibb. Check Bristol Myers' Beneish M Score to see the likelihood of Bristol Myers' management manipulating its earnings.

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.